Related Experiment Video

Updated: Aug 6, 2026

Inducible and Reversible Dominant-negative (DN) Protein Inhibition
08:35

Inducible and Reversible Dominant-negative (DN) Protein Inhibition

Published on: January 7, 2019

The retinoid anticancer signal: mechanisms of target gene regulation

T Liu1, A Bohlken, S Kuljaca

  • 1Children's Cancer Institute Australia for Medical Research, Randwick NSW 2031, Australia.

British Journal of Cancer
|July 14, 2005
PubMed

Insights

Cancer cell sensitivity to retinoids depends on how key genes respond. Researchers identified specific retinoid-regulated genes (like RARbeta2, DUSP6, RGS16) that correlate with cancer cell growth arrest and differentiation, offering new therapeutic targets.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Genetics

Background:

  • Retinoids are known to induce anti-cancer effects like growth arrest and differentiation in various cancer cells.
  • Cancer cell sensitivity to retinoids is influenced by the transcriptional response of retinoid-regulated target genes.
  • Understanding these gene responses is crucial for developing effective retinoid-based cancer therapies.

Purpose of the Study:

  • To identify retinoid-regulated target genes common to retinoid-sensitive neuroblastoma cell lines.
  • To determine the correlation between the expression patterns of these target genes and retinoid sensitivity in different cancer cell lines (neuroblastoma, lung, breast).
  • To investigate the role of specific target genes (e.g., RARbeta2, CYP26A1, DUSP6, RGS16) in mediating the retinoid anticancer response in vitro and in vivo.

Main Methods:

  • Utilized cDNA microarray to identify 31 shared retinoid-regulated target genes in neuroblastoma cell lines.
  • Assessed retinoid responsiveness of selected target genes across sensitive and resistant lung and breast cancer cell lines.
  • Investigated gene expression changes in neuroblastoma tumors from MYCN transgenic mice treated with retinoids.
  • Examined the functional impact of inhibiting specific genes (RARbeta2, DUSP6, RGS16) on retinoid-induced cellular responses and signaling pathways (e.g., ERK phosphorylation).

Main Results:

  • Identified 31 retinoid-regulated target genes common to sensitive neuroblastoma cells.
  • Six of 13 genes (RARbeta2, CYP26A1, CRBP1, RGS16, DUSP6, EGR1) showed responsiveness patterns correlating with retinoid sensitivity in lung and breast cancer cells.
  • Retinoid treatment altered expression of 5 out of 9 examined genes in neuroblastoma tumors in vivo.
  • Inhibition of RARbeta2 only blocked CYP26A1 induction, while combined inhibition of DUSP6 and RGS16 was necessary to block retinoid-induced growth inhibition in neuroblastoma cells via ERK signaling.

Conclusions:

  • The transcriptional response of key retinoid-regulated target genes, including RARbeta2, DUSP6, and RGS16, partially determines cancer cell sensitivity to retinoids.
  • Specific gene expression patterns serve as biomarkers for retinoid sensitivity.
  • Targeting multiple genes like DUSP6 and RGS16 may be a more effective strategy for overcoming retinoid resistance.

More Related Videos

An In Vitro Protocol for Evaluating MicroRNA Levels, Functions, and Associated Target Genes in Tumor Cells09:45

An In Vitro Protocol for Evaluating MicroRNA Levels, Functions, and Associated Target Genes in Tumor Cells

Published on: May 21, 2019

Quantitative Analysis of Dietary Vitamin A Metabolites in Murine Ocular and Non-Ocular Tissues Using High-Performance Liquid Chromatography05:03

Quantitative Analysis of Dietary Vitamin A Metabolites in Murine Ocular and Non-Ocular Tissues Using High-Performance Liquid Chromatography

Published on: December 27, 2024

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR activation may...
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Transducer Mechanism: Enzyme-Linked Receptors01:27

Transducer Mechanism: Enzyme-Linked Receptors

Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include: